SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950115-00-000822
Filing Date
2000-06-13
Accepted
2000-06-13 00:00:00
Documents
9
Period of Report
2000-04-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT 0001.txt 10-Q 65048
2 SECURUTIES PURCHASE AGREEMENT 0002.txt EX-4.1 72715
3 SECURITIES PURCHASE AGREEMENT (US) 0003.txt EX-4.2 66725
4 REGISTRATION RIGHTS AGREEMENT 0004.txt EX-4.3 65352
5 REGISTRATION RIGHTS AGREEMENT (US) 0005.txt EX-4.4 63746
6 WARRANT 0006.txt EX-4.5 53009
7 WARRANT 0007.txt EX-4.6 50932
8 WARRANT 0008.txt EX-4.7 49359
9 FDS -- 0009.txt EX-27 2012
  Complete submission text file 0000950115-00-000822.txt   491389
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO M5J A1
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-25169 | Film No.: 654105
SIC: 2834 Pharmaceutical Preparations